3 completed. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow Nut Hypersensitivity: new trials by email Literature Review of Nut Hypersensitivity trials Research Report on Nut Hypersensitivity
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preventing Anaphylaxis With Acalabrutinib Acalabrutinib - Food Allergy, Food Allergy Peanut | Phase 2 | Completed | Johns Hopkins University | 10 | 2021-12-16 | 2023-09-28 |
| ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults Low dose ADP101, High dose ADP101, Pooled Placebo - Food Allergy | Phase 1 / Phase 2 | Completed | Alladapt Immunotherapeutics, Inc. | 73 | 2021-04-20 | 2024-05-16 |
| Walnut Oral Immunotherapy for Tree Nut Allergy Walnut Protein Powder, Oat Powder (placebo), Open-label Walnut Protein Powder - Tree Nut Allergy | Phase 1 / Phase 2 | Completed | University of Arkansas | 22 | 2012-04-27 | 2023-05-12 |
Food Hypersensitivity (3) · Hypersensitivity (2) · Peanut Hypersensitivity (2) · Anaphylaxis (1) · Egg Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Milk Hypersensitivity (1) · Shellfish Hypersensitivity (1) · Wheat Hypersensitivity (1)
Nut and Peanut Hypersensitivity (3) · Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Hypersensitivity (1)
acalabrutinib (1)
Alladapt Immunotherapeutics, Inc. (1) · Johns Hopkins University (1) · University of Arkansas (1)
United States (3)
Mei-Lun Wang, MD (1) · Melanie C. Dispenza, MD, PhD (1) · Stacie M Jones, MD (1)